Active ingredientAlendronic AcidCat. No. P-A071-001CAS 66376-36-1Family · Pharmaceutical analytical standards
Alendronic Acid
A nitrogen-containing bisphosphonate described in 1978 that slows bone resorption by osteoclasts; approved in the United States in 1995, it is used for osteoporosis and Paget's disease. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Less than 1% of an oral dose is absorbed, but the part that binds to bone stays there for a long time: its half-life in the skeleton is estimated at about ten years.
Go to the active ingredient →Active ingredientAlendronic AcidCat. No. P-A071-001CAS 66376-36-1
Isotopically labelledAlendronic Acid-d6Cat. No. P-A071-002CAS 1035437-39-8
Isotopically labelledTetramethyl N,N,O-Trimethyl Alendronate-d6Cat. No. P-A071-003
Impurity2-Pyrrolidinylphosphonic AcidCat. No. P-A071-004CAS 73858-59-0
ImpurityAlendronic Acid Impurity 1Cat. No. P-A071-005
ImpurityAlendronic Acid Impurity 2Cat. No. P-A071-006
ImpurityAlendronic Acid Impurity 3Cat. No. P-A071-007CAS 2763925-95-5
ImpurityAlendronic Acid Impurity 4Cat. No. P-A071-008
Active ingredientAlendronate SodiumCat. No. P-A071-009CAS 129318-43-0
ImpurityAlendronic Acid Dimeric AnhydrideCat. No. P-A071-010CAS 165043-20-9
ImpurityAlendronic Acid Impurity 5Cat. No. P-A071-011CAS 165043-19-6
Active ingredientSodium AlendronateCat. No. P-A071-012CAS 121268-17-5
ImpurityTetramethyl N,N,O-Trimethyl AlendronateCat. No. P-A071-013No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceSodium alendronate trihydrate CRSEDQM code Y0001727Family Alendronic AcidNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.